Post-bachelor or post-master's position: Staphylococcus phage therapy
| Application timing | Mar 28, 2019 — Deadline: 12/31/2019 3:00 |
|---|
A research opportunity is available in the Division of Bacterial, Parasitic and Allergenic Products (DBPAP) within the Food and Drug Administration (FDA) in Silver Spring, Maryland. This project is aimed at evaluating the use of bacteriophage to treat Staphyloccocus aureus colonization and/or disease in order to better combat multi-antibiotic-resistant bacterial pathogens.
Topics
| Original listing | FDA, Silver Spring, MD |
|---|